NEW YORK (GenomeWeb News) – Agilent Technologies and Roche today announced that Agilent will provide service to NimbleGen microarray customers as Roche shutters that business.

Researchers using NimbleGen microarrays for all applications can transition to Agilent arrays, effective immediately with minimal disruptions, the companies said. Because of the similarities of the two firms' technologies and products, Agilent microarrays can be run on the NimbleGen MS200 Microarray Scanner.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.